Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Henry Patton Doggrell Insider Profile
4 Followers
Henry Patton Doggrell, VP, Chief Legal Officer at Oncternal Therapeutics, holds 48.17K shares in Oncternal Therapeutics (Ticker: ONCT). Most recently, Henry Patton Doggrell Sold $7,351 shares of Oncternal Therapeutics on Jun 22, 2018 for an estimated value of 139.67K.
Henry Patton Doggrell Oncternal Therapeutics (ONCT)VP, Chief Legal Officer
Oncternal Therapeutics (ONCT)
VP, Chief Legal Officer
Ranked #13,430 out of 98,909 Corporate Insiders
Profitable Transactions
2 out of 4 Profitable Transactions
Average Return
+39.50%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Henry Patton Doggrell's holdings
Insider Roles
VP, Chief Legal Officer
Roles that Henry Patton Doggrell holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Jun 22, 2018 - Jun 22, 2019
Return:+94.30%
The most profitable trade made by Henry Patton Doggrell
Henry Patton Doggrell's Trading History
List of latest transactions for each holding click on a transaction to see Henry Patton Doggrell's performance on stock
You May Also Like
Henry Patton Doggrell insider profile FAQ
What is the percentage of profitable transactions made by Henry Patton Doggrell?
The percentage of profitable transactions made by Henry Patton Doggrell is 50%.
What is the average return per transaction made by Henry Patton Doggrell?
The average return per transaction made by Henry Patton Doggrell is 39.50%.
What stocks does Henry Patton Doggrell hold?
Henry Patton Doggrell holds: ONCT stocks.
What was Henry Patton Doggrell’s latest transaction?
Henry Patton Doggrell latest transaction was an Informative Sell of $139.67K.
What was Henry Patton Doggrell's most profitable transaction?
Henry Patton Doggrell’s most profitable transaction was an Informative Sell of ONCT stock on June 22, 2018. The return on the trade was 94.30%.
What is Henry Patton Doggrell's role in Oncternal Therapeutics?
Henry Patton Doggrell's role in Oncternal Therapeutics is VP, Chief Legal Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.